ArticleMolecular cancer2024
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients.
Sylvia Zöphel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleMolecular cancer2024
Sylvia Zöphel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.